Stem Cell Extracellular Vesicles: Extended messages of regeneration

Annual Review of Pharmacology and Toxicology

Volumn 57, Issue , 2017, Pages 125-154

  Riazifar, Milad ^a,b,c,d   Pone, Egest J ^a,b,c,d   Lotval, Jan ^a,e,f   Zhao, Weian ^a,b,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c University of California at Irvine   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

^f NONE   (United States)

Author keywords

Bioengineering; Drug delivery; Exosomes; Extracellular vesicles; Microvesicles; Stem cells

Indexed keywords

BIOLOGICAL MARKER; LIPOSOME; MORPHOGEN; NANOPARTICLE; NUCLEIC ACID;

BIOCOMPATIBILITY; BIOENGINEERING; CELL DIFFERENTIATION; CELL ENGINEERING; CELL GROWTH; EMBRYO DEVELOPMENT; EXOSOME; HOMEOSTASIS; HUMAN; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STEADY STATE; STEM CELL; TISSUE REGENERATION; ANIMAL; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; PROCEDURES; REGENERATION; TRENDS;

ANIMALS; BIOENGINEERING; CELL DIFFERENTIATION; EXOSOMES; EXTRACELLULAR VESICLES; HUMANS; NANOPARTICLES; REGENERATION; STEM CELLS;

EID: 85009084360     PISSN: 03621642     EISSN: 15454304     Source Type: Book Series    
DOI: 10.1146/annurev-pharmtox-061616-030146     Document Type: Review

References (213)

1. ColomboM, RaposoG, Théry C. 2014. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu. Rev. Cell Dev. Biol. 30:255-89
2. Yanez-Mo M, Siljander PR, Andreu Z, Zavec AB, Borras FE, et al. 2015. Biological properties of extracellular vesicles and their physiological functions. J. Extracell. Vesicles 4:27066
3. Record M, Subra C, Silvente-Poirot S, Poirot M. 2011. Exosomes as intercellular signalosomes and pharmacological effectors. Biochem. Pharmacol. 81:1171-82
4. Villarroya-Beltri C, Baixauli F, Gutiérrez-Vázquez C, Sánchez-Madrid F,Mittelbrunn M. 2014. Sorting it out: regulation of exosome loading. Semin. Cancer Biol. 28:3-13
5. Mulcahy LA, Pink RC, Carter DR. 2014. Routes and mechanisms of extracellular vesicle uptake. J. Extracell. Vesicles 3:24641
6. Lakkaraju A, Rodriguez-Boulan E. 2008. Itinerant exosomes: emerging roles in cell and tissue polarity. Trends Cell Biol. 18:199-209
7. Clevers H, Loh KM, Nusse R. 2014. An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control. Science 346:1248012
8. Zhang L,Wrana JL. 2014. The emerging role of exosomes inWnt secretion and transport. Curr. Opin. Genet. Dev. 27:14-19
9. Camussi G, Deregibus MC, Cantaluppi V. 2013. Role of stem-cell-derived microvesicles in the paracrine action of stem cells. Biochem. Soc. Trans. 41:283-87
10. Quesenberry P, Aliotta J, Dooner M, Chatterjee D, Ramratnam B, et al. 2014. Extracellular vesicles and tissue organ regeneration. In Adult Stem Cell Therapies: Alternatives to Plasticity, ed. MZ Ratajczak, pp. 245-50. New York: Springer
11. Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, et al. 2009. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5:54-63
12. Walker PA, Letourneau PA, Bedi S, Shah SK, Jimenez F, Cox CS Jr. 2011. Progenitor cells as remote "bioreactors": neuroprotection via modulation of the systemic inflammatory response. World J. Stem Cells 3:9-18
13. Kourembanas S. 2015. Exosomes: vehicles of intercellular signaling, biomarkers, and vectors of cell therapy. Annu. Rev. Physiol. 77:13-27
14. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, et al. 2001. Bone marrow cells regenerate infarcted myocardium. Nature 410:701-5
15. Nygren JM, Jovinge S, Breitbach M, Sawen P, RollW, et al. 2004. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat. Med. 10:494-501
16. GnecchiM,HeHM, Liang OD, Melo LG, Morello F, et al. 2005. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat. Med. 11:367-68
17. Belting M, Wittrup A. 2008. Nanotubes, exosomes, and nucleic acid-binding peptides provide novel mechanisms of intercellular communication in eukaryotic cells: implications in health and disease. J. Cell Biol. 183:1187-91
18. Lim K, Hyun YM, Lambert-Emo K, Capece T, Bae S, et al. 2015. Neutrophil trails guide influenzaspecific CD8+ T cells in the airways. Science 349:aaa4352
19. Gÿorgy B, Hung ME, Breakefield XO, Leonard JN. 2015. Therapeutic applications of extracellular vesicles: clinical promise and open questions. Annu. Rev. Pharmacol. Toxicol. 55:439-64
20. Quesenberry PJ, Aliotta J, Deregibus MC, Camussi G. 2015. Role of extracellular RNA-carrying vesicles in cell differentiation and reprogramming. Stem Cell Res. Ther. 6:153
21. Wang AZ, Langer R, Farokhzad OC. 2012. Nanoparticle delivery of cancer drugs. Annu. Rev. Med. 63:185-98
22. Torchilin VP. 2014. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nat. Rev. Drug Discov. 13:813-27
23. Lötvall J, Hill AF, Hochberg F, Buzas EI, Di Vizio D, et al. 2014. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J. Extracell. Vesicles 3:26913
24. Pan BT, Teng K, Wu C, Adam M, Johnstone RM. 1985. Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes. J. Cell Biol. 101:942-48
25. Zomer A, Maynard C, Verweij FJ, Kamermans A, Schafer R, et al. 2015. In vivo imaging reveals extracellular vesicle-mediated phenocopying of metastatic behavior. Cell 161:1046-57
26. Kanada M, Bachmann MH, Hardy JW, Frimannson DO, Bronsart L, et al. 2015. Differential fates of biomolecules delivered to target cells via extracellular vesicles. PNAS 112:E1433-42
27. Andreu Z, Yanez-Mo M. 2014. Tetraspanins in extracellular vesicle formation and function. Front. Immunol. 5:442
28. Roberts CT Jr., Kurre P. 2013. Vesicle trafficking and RNA transfer add complexity and connectivity to cell-cell communication. Cancer Res. 73:3200-5
29. Cocucci E, Meldolesi J. 2015. Ectosomes and exosomes: shedding the confusion between extracellular vesicles. Trends Cell Biol. 25:364-72
30. Henson PM, Bratton DL. 2013. Antiinflammatory effects of apoptotic cells. J. Clin. Investig. 123:2773-74
31. Getts DR, McCarthy DP, Miller SD. 2013. Exploiting apoptosis for therapeutic tolerance induction. J. Immunol. 191:5341-46
32. Robbins PD, Morelli AE. 2014. Regulation of immune responses by extracellular vesicles. Nat. Rev. Immunol. 14:195-208
33. Bissig C, Gruenberg J. 2013. Lipid sorting and multivesicular endosome biogenesis. Cold Spring Harb. Perspect. Biol. 5:a016816
34. Marzesco AM. 2013. Prominin-1-containing membrane vesicles: origins, formation, and utility. Adv. Exp. Med. Biol. 777:41-54
35. Fargeas CA. 2013. Prominin-2 and other relatives of CD133. Adv. Exp. Med. Biol. 777:25-40
36. Pattabiraman DR, Weinberg RA. 2014. Tackling the cancer stem cells-what challenges do they pose Nat. Rev. Drug Discov. 13:497-512
37. Zhang XA, Huang C. 2012. Tetraspanins and cell membrane tubular structures. Cell. Mol. Life Sci. 69:2843-52
38. Cal òA,Reguera D, OncinsG, PersuyMA, Sanz G, et al. 2014. Forcemeasurements on natural membrane nanovesicles reveal a composition-independent, high Young's modulus. Nanoscale 6:2275-85
39. Mittelbrunn M, Sánchez-Madrid F. 2012. Intercellular communication: diverse structures for exchange of genetic information. Nat. Rev. Mol. Cell Biol. 13:328-35
40. Diehl P, Fricke A, Sander L, Stamm J, Bassler N, et al. 2012. Microparticles: major transport vehicles for distinct microRNAs in circulation. Cardiovasc. Res. 93:633-44
41. Valadi H, Ekstr öm K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. 2007. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9:654-59
42. Fatica A, Bozzoni I. 2014. Long non-coding RNAs: new players in cell differentiation and development. Nat. Rev. Genet. 15:7-21
43. Ha M, Kim VN. 2014. Regulation of microRNA biogenesis. Nat. Rev. Mol. Cell. Biol. 15:509-24
44. Morris KV, Mattick JS. 2014. The rise of regulatory RNA. Nat. Rev. Genet. 15:423-37
45. Kholodenko BN, Hancock JF, Kolch W. 2010. Signalling ballet in space and time. Nat. Rev. Mol. Cell. Biol. 11:414-26
46. Vieira AV, Lamaze C, Schmid SL. 1996. Control of EGF receptor signaling by clathrin-mediated endocytosis. Science 274:2086-89
47. Sigismund S, Confalonieri S, Ciliberto A, Polo S, ScitaG,Di Fiore PP. 2012. Endocytosis and signaling: cell logistics shape the eukaryotic cell plan. Physiol. Rev. 92:273-366
48. Marjon KD, Gillette JM. 2014. Measurement of intercellular transfer to signaling endosomes. Methods Enzymol. 534:207-21
49. Denzer K, Kleijmeer MJ, Heijnen HF, StoorvogelW, Geuze HJ. 2000. Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J. Cell Sci. 113:3365-74
50. Mause SF, Weber C. 2010. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ. Res. 107:1047-57
51. Corrado C, Raimondo S, Chiesi A, Ciccia F, De Leo G, Alessandro R. 2013. Exosomes as intercellular signaling organelles involved in health and disease: basic science and clinical applications. Intl. J. Mol. Sci. 14:5338-66
52. Gangoda L, Boukouris S, Liem M, Kalra H, Mathivanan S. 2015. Extracellular vesicles including exosomes are mediators of signal transduction: Are they protective or pathogenic Proteomics 15:260-71
53. Singh B, Coffey RJ. 2014. Trafficking of epidermal growth factor receptor ligands in polarized epithelial cells. Annu. Rev. Physiol. 76:275-300
54. Poss KD. 2010. Advances in understanding tissue regenerative capacity and mechanisms in animals. Nat. Rev. Genet. 11:710-22
55. Mittelbrunn M, Vicente-Manzanares M, Sánchez-Madrid F. 2015. Organizing polarized delivery of exosomes at synapses. Traffic 16:327-37
56. Gross JC, Chaudhary V, Bartscherer K, BoutrosM. 2012. Active Wnt proteins are secreted on exosomes. Nat. Cell Biol. 14:1036-45
57. vanNielG, RaposoG, Candalh C, BoussacM,Hershberg R, et al. 2001. Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology 121:337-49
58. Rodriguez-Boulan E, Macara IG. 2014. Organization and execution of the epithelial polarity programme. Nat. Rev. Mol. Cell. Biol. 15:225-42
59. Gradilla AC, Guerrero I. 2013. Cytoneme-mediated cell-to-cell signaling during development. Cell Tissue Res. 352:59-66
60. Graham TR, Kozlov MM. 2010. Interplay of proteins and lipids in generating membrane curvature. Curr. Opin. Cell Biol. 22:430-36
61. Kornberg TB, Roy S. 2014. Cytonemes as specialized signaling filopodia. Development 141:729-36
62. Stanganello E, Hagemann AI, Mattes B, Sinner C,Meyen D, et al. 2015. Filopodia-basedWnt transport during vertebrate tissue patterning. Nat. Commun. 6:5846
63. Plotnikov EY, Khryapenkova TG, Vasileva AK,MareyMV,Galkina SI, et al. 2008. Cell-to-cell cross-talk between mesenchymal stem cells and cardiomyocytes in co-culture. J. Cell. Mol. Med. 12:1622-31
64. Cismasiu VB, Popescu LM. 2015. Telocytes transfer extracellular vesicles loaded with microRNAs to stem cells. J. Cell Mol. Med. 19:351-58
65. Tersteeg C, Heijnen HF, Eckly A, Pasterkamp G, Urbanus RT, et al. 2014. FLow-induced PRotrusions (FLIPRs): a platelet-derived platform for the retrieval of microparticles by monocytes and neutrophils. Circ. Res. 114:780-91
66. Sørensen OE, Borregaard N. 2016. Neutrophil extracellular traps- The dark side of neutrophils. J. Clin. Investig. 126:1612-20
67. Arraud N, Linares R, Tan S, Gounou C, Pasquet JM, et al. 2014. Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype and concentration. J. Thromb. Haemost. 12:614-27
68. Wood CR, Rosenbaum JL. 2015. Ciliary ectosomes: transmissions from the cell's antenna. Trends Cell Biol. 25:276-85
69. Wang J, Silva M, Haas LA, Morsci NS, Nguyen KC, et al. 2014. C. Elegans ciliated sensory neurons release extracellular vesicles that function in animal communication. Curr. Biol. 24:519-25
70. Korkut C, Ataman B, Ramachandran P, Ashley J, Barria R, et al. 2009. Trans-synaptic transmission of vesicular Wnt signals through Evi/Wntless. Cell 139:393-404
71. Koles K, Nunnari J, Korkut C, Barria R, Brewer C, et al. 2012. Mechanism of evenness interrupted (Evi)-exosome release at synaptic boutons. J. Biol. Chem. 287:16820-34
72. Panáková D, Sprong H, Marois E, Thiele C, Eaton S. 2005. Lipoprotein particles are required for Hedgehog andWingless signalling. Nature 435:58-65
73. Greco V, Hannus M, Eaton S. 2001. Argosomes: a potential vehicle for the spread of morphogens through epithelia. Cell 106:633-45
74. Beckett K,Monier S, Palmer L, Alexandre C, Green H, et al. 2013. Drosophila S2 cells secrete wingless on exosome-like vesicles but the wingless gradient forms independently of exosomes. Traffic 14:82-96
75. Tanaka Y, Okada Y, Hirokawa N. 2005. FGF-induced vesicular release of Sonic hedgehog and retinoic acid in leftward nodal flow is critical for left-right determination. Nature 435:172-77
76. Vyas N, Walvekar A, Tate D, Lakshmanan V, Bansal D, et al. 2014. Vertebrate Hedgehog is secreted on two types of extracellular vesicles with different signaling properties. Sci. Rep. 4:7357
77. Liégeois S, Benedetto A, Garnier JM, Schwab Y, Labouesse M. 2006. The V0-ATPase mediates apical secretion of exosomes containing Hedgehog-related proteins in Caenorhabditis elegans. J. Cell Biol. 173:949-61
78. Taelman VF, Dobrowolski R, Plouhinec JL, Fuentealba LC, Vorwald PP, et al. 2010. Wnt signaling requires sequestration of glycogen synthase kinase 3 inside multivesicular endosomes. Cell 143:1136-48
79. Cruciat CM,Ohkawara B, Acebron SP, Karaulanov E, Reinhard C, et al. 2010. Requirement of prorenin receptor and vacuolar H+-ATPase-mediated acidification for Wnt signaling. Science 327:459-63
80. Sheldon H, Heikamp E, Turley H, Dragovic R, Thomas P, et al. 2010. New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomes. Blood 116:2385-94
81. Sharghi-Namini S, Tan EV, Ong LLS, Ge RW, Asada HH. 2014. Dll4-containing exosomes induce capillary sprout retraction in a 3D microenvironment. Sci. Rep. 4:4031
82. Guruharsha KG, KankelMW, Artavanis-Tsakonas S. 2012. TheNotch signalling system: recent insights into the complexity of a conserved pathway. Nat. Rev. Genet. 13:654-66
83. Ryoo HD, Bergmann A. 2012. The role of apoptosis-induced proliferation for regeneration and cancer. Cold Spring Harb. Perspect. Biol. 4:a008797
84. Poon IK, Lucas CD, Rossi AG, Ravichandran KS. 2014. Apoptotic cell clearance: basic biology and therapeutic potential. Nat. Rev. Immunol. 14:166-80
85. JanssenWJ, Henson PM. 2012. Cellular regulation of the inflammatory response. Toxicol. Pathol. 40:166-73
86. Tso GH, Law HK, Tu W, Chan GC, Lau YL. 2010. Phagocytosis of apoptotic cells modulates mesenchymal stem cells osteogenic differentiation to enhance IL-17 and RANKL expression on CD4+ T cells. Stem Cells 28:939-54
87. Deregibus MC, Iavello A, Tetta C, Camussi G. 2014. Role of extracellular vesicles in tissue/organ regeneration. In Adult Stem Cell Therapies: Alternatives to Plasticity, ed. MZ Ratajczak, pp. 231-44. New York: Springer
88. Aliotta JM, Sanchez-Guijo FM,Dooner GJ, Johnson KW,Dooner MS, et al. 2007. Alteration of marrow cell gene expression, protein production, and engraftment into lung by lung-derived microvesicles: a novel mechanism for phenotype modulation. Stem Cells 25:2245-56
89. Aliotta JM, Pereira M, Johnson KW, de Paz N, Dooner MS, et al. 2010. Microvesicle entry into marrow cells mediates tissue-specific changes in mRNA by direct delivery of mRNA and induction of transcription. Exp. Hematol. 38:233-45
90. Renzulli JF II, Del Tatto M, Dooner G, Aliotta J, Goldstein L, et al. 2010. Microvesicle induction of prostate specific gene expression in normal human bone marrow cells. J. Urol. 184:2165-71
91. Aliotta JM, Lee D, Puente N, Faradyan S, Sears EH, et al. 2012. Progenitor/stem cell fate determination: interactive dynamics of cell cycle and microvesicles. Stem Cells Dev. 21:1627-38
92. Aliotta JM, Pereira M, Li M, Amaral A, Sorokina A, et al. 2012. Stable cell fate changes in marrow cells induced by lung-derived microvesicles. J. Extracell. Vesicles 1:18163
93. Aliotta JM, Pereira M, Amaral A, Sorokina A, Igbinoba Z, et al. 2013. Induction of pulmonary hypertensive changes by extracellular vesicles from monocrotaline-treated mice. Cardiovasc. Res. 100:354-62
94. O'Brien LE, Bilder D. 2013. Beyond the niche: tissue-level coordination of stem cell dynamics. Annu. Rev. Cell Dev. Biol. 29:107-36
95. Ben-David U, Benvenisty N. 2011. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat. Rev. Cancer 11:268-77
96. Zakrzewski JL, van den Brink MR, Hubbell JA. 2014. Overcoming immunological barriers in regenerative medicine. Nat. Biotechnol. 32:786-94
97. Cvjetkovic A, Lötvall J, Lässer C. 2014. The influence of rotor type and centrifugation time on the yield and purity of extracellular vesicles. J. Extracell. Vesicles 3:23111
98. Nordin JZ, Lee Y, Vader P, Mäger I, Johansson HJ, et al. 2015. Ultrafiltration with size-exclusion liquid chromatography for high yield isolation of extracellular vesicles preserving intact biophysical and functional properties. Nanomedicine 11:879-83
99. Heinemann ML, Ilmer M, Silva LP, Hawke DH, Recio A, et al. 2014. Benchtop isolation and characterization of functional exosomes by sequential filtration. J. Chromatogr. A 1371C:125-35
100. Kilpinen L, Impola U, Sankkila L, Ritamo I, Aatonen M, et al. 2013. Extracellular membrane vesicles from umbilical cord blood-derived MSC protect against ischemic acute kidney injury, a feature that is lost after inflammatory conditioning. J. Extracell. Vesicles 2:21927
101. Wahlgren J, De L Karlson T, Brisslert M, Vaziri Sani F, Telemo E, et al. 2012. Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes. Nucleic. Acids. Res. 40:e130
102. SmythT, Petrova K, Payton NM, Persaud I, Redzic JS, et al. 2014. Surface functionalization of exosomes using click chemistry. Bioconjug. Chem. 25:1777-84
103. Vallhov H, Gutzeit C, Johansson SM, Nagy N, Paul M, et al. 2011. Exosomes containing glycoprotein 350 released by EBV-transformedBcells selectively targetBcells throughCD21 and blockEBVinfection in vitro. J. Immunol. 186:73-82
104. Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ. 2011. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 29:341-45
105. Clayton A, Harris CL, Court J, Mason MD, Morgan BP. 2003. Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59. Eur. J. Immunol. 33:522-31
106. Chao MP, Weissman IL, Majeti R. 2012. The CD47-SIRP pathway in cancer immune evasion and potential therapeutic implications. Curr. Opin. Immunol. 24:225-32
107. Perycz M, Urbanska AS, Krawczyk PS, Parobczak K, Jaworski J. 2011. Zipcode binding protein 1 regulates the development of dendritic arbors in hippocampal neurons. J. Neurosci. 31:5271-85
108. Juliano C,Wang J, Lin H. 2011. Uniting germline and stem cells: the function of Piwi proteins and the piRNA pathway in diverse organisms. Annu. Rev. Genet. 45:447-69
109. Tian Y, Li S, Song J, Ji T, ZhuM, et al. 2014. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials 35:2383-90
110. Zhuang X, Xiang X, Grizzle W, Sun D, Zhang S, et al. 2011. Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol. Ther. 19:1769-79
111. Katsuda T, Kosaka N, Takeshita F, Ochiya T. 2013. The therapeutic potential of mesenchymal stem cell-derived extracellular vesicles. Proteomics 13:1637-53
112. Lee JK, Jang JY, Jeon YK, Kim CW. 2014. Extracellular vesicles as an emerging paradigm of cell-to-cell communication in stem cell biology. J. Stem. Cell Res. Ther. 4:206
113. Lamichhane TN, Sokic S, Schardt JS, Raiker RS, Lin JW, Jay SM. 2015. Emerging roles for extracellular vesicles in tissue engineering and regenerative medicine. Tissue Eng. Part B Rev. 21:45-54
114. Rani S, Ryan AE, Griffin MD, Ritter T. 2015. Mesenchymal stem cell-derived extracellular vesicles: toward cell-free therapeutic applications. Mol. Ther. 23:812-23
115. Katsman D, Stackpole EJ, Domin DR, Farber DB. 2012. Embryonic stem cell-derived microvesicles induce gene expression changes in Müller cells of the retina. PLOS ONE 7:e50417
116. Khan M, Nickoloff E, Abramova T, Johnson J, Verma SK, et al. 2015. Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction. Circ. Res. 117:52-64
117. Deregibus MC, Cantaluppi V, Calogero R, Lo Iacono M, Tetta C, et al. 2007. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 110:2440-48
118. Cantaluppi V, Biancone L, Figliolini F, Beltramo S,Medica D, et al. 2012. Microvesicles derived from endothelial progenitor cells enhance neoangiogenesis of human pancreatic islets. Cell Transplant. 21:1305-20
119. Ibrahim AGE, Cheng K,Marban E. 2014. Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Rep. 2:606-19
120. Cahan P, DaleyGQ. 2013. Origins and implications of pluripotent stem cell variability and heterogeneity. Nat. Rev. Mol. Cell Biol. 14:357-68
121. Lalu MM, McIntyre L, Pugliese C, Fergusson D,Winston BW, et al. 2012. Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review andmeta-analysis of clinical trials. PLOS ONE 7:e47559
122. Heldring N, Mäger I, Wood MJA, Le Blanc K, Andaloussi SEL. 2015. Therapeutic potential of multipotent mesenchymal stromal cells and their extracellular vesicles. Hum. Gene Ther. 26:506-17
123. Stuckey DW, Shah K. 2014. Stem cell-based therapies for cancer treatment: separating hope from hype. Nat. Rev. Cancer 14:683-91
124. Sordi V, Melzi R, Mercalli A, Formicola R, Doglioni C, et al. 2010. Mesenchymal cells appearing in pancreatic tissue culture are bone marrow-derived stem cells with the capacity to improve transplanted islet function. Stem Cells 28:140-51
125. Singer NG, Caplan AI. 2011. Mesenchymal stem cells: mechanisms of inflammation. Annu. Rev. Pathol. Mech. Dis. 6:457-78
126. Frenette PS, Pinho S, Lucas D, Scheiermann C. 2013. Mesenchymal stem cell: keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine. Annu. Rev. Immunol. 31:285-316
127. He J, Wang Y, Sun S, YuM,Wang C, et al. 2012. Bone marrow stem cells-derived microvesicles protect against renal injury in the mouse remnant kidney model. Nephrology 17:493-500
128. Bruno S,GrangeC,Deregibus MC, Calogero RA, Saviozzi S, et al. 2009. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J. Am. Soc. Nephrol. 20:1053-67
129. Tan CY, Lai RC, Wong W, Dan YY, Lim SK, Ho HK. 2014. Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models. Stem Cell Res. Ther. 5:76
130. Zhang B,WangM, Gong A, Zhang X, Wu X, et al. 2014. HucMSC-exosome mediated-Wnt4 signaling is required for cutaneous wound healing. Stem Cells 33:2158-68
131. Zhu YG, Feng XM, Abbott J, Fang XH, HaoQ, et al. 2014. Humanmesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice. Stem Cells 32:116-25
132. Lee C, Mitsialis SA, Aslam M, Vitali SH, Vergadi E, et al. 2012. Exosomes mediate the cytoprotective action ofmesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation 126:2601-11
133. Arslan F, Lai RC, Smeets MB, Akeroyd L,Choo A, et al. 2013. Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Res. 10:301-12
134. Xin H, Li Y, Liu Z, Wang X, Shang X, et al. 2013. MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles. Stem Cells 31:2737-46
135. Xin H, Li Y, Cui Y, Yang JJ, Zhang ZG, Chopp M. 2013. Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J. Cereb. Blood Flow Metab. 33:1711-15
136. Kordelas L, Rebmann V, Ludwig AK, Radtke S, Ruesing J, et al. 2014. MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease. Leukemia 28:970-73
137. Arwert EN, Hoste E, Watt FM. 2012. Epithelial stem cells, wound healing and cancer. Nat. Rev. Cancer 12:170-80
138. MinciacchiVR, Freeman MR,Di Vizio D. 2015. Extracellular vesicles in cancer: exosomes,microvesicles and the emerging role of large oncosomes. Semin. Cell Dev. Biol. 40:41-51
139. Webber J, Yeung V, Clayton A. 2015. Extracellular vesicles as modulators of the cancer microenvironment. Sem. Cell Dev. Biol. 40:27-34
140. Kalluri R. 2016. The biology and function of exosomes in cancer. J. Clin. Investig. 126:1208-15
141. Valent P, Bonnet D, De Maria R, Lapidot T, Copland M, et al. 2012. Cancer stem cell definitions and terminology: The devil is in the details. Nat. Rev. Cancer 12:767-75
142. Stange DE, Clevers H. 2013. Concise review: the yin and yang of intestinal (cancer) stem cells and their progenitors. Stem Cells 31:2287-95
143. Medema JP. 2013. Cancer stem cells: the challenges ahead. Nat. Cell Biol. 15:338-44
144. Rycaj K, Tang DG. 2015. Cell-of-origin of cancer versus cancer stem cells: assays and interpretations. Cancer Res. 75:4003-11
145. Hannafon BN, Ding WQ. 2015. Cancer stem cells and exosome signaling. Stem Cell Investig. 2:11
146. Muralidharan-Chari V, Clancy JW, Sedgwick A, D'Souza-Schorey C. 2010. Microvesicles: mediators of extracellular communication during cancer progression. J. Cell Sci. 123:1603-11
147. Plaks V, Kong NW, Werb Z. 2015. The cancer stem cell niche: How essential is the niche in regulating stemness of tumor cells Cell Stem Cell 16:225-38
148. Egeblad M, Nakasone ES, Werb Z. 2010. Tumors as organs: complex tissues that interface with the entire organism. Dev. Cell 18:884-901
149. Bissell MJ, Hines WC. 2011. Why don't we get more cancer A proposed role of the microenvironment in restraining cancer progression. Nat. Med. 17:320-29
150. McAllister SS, Weinberg RA. 2014. The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nat. Cell Biol. 16:717-27
151. Vallabhaneni KC, Penfornis P, Dhule S, Guillonneau F, Adams KV, et al. 2015. Extracellular vesicles from bone marrow mesenchymal stem/stromal cells transport tumor regulatory microRNA, proteins, and metabolites. Oncotarget 6:4953-67
152. Grange C, Tapparo M, Collino F, Vitillo L, Damasco C, et al. 2011. Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res. 71:5346-56
153. Fonsato V, Collino F, Herrera MB, Cavallari C, Deregibus MC, et al. 2012. Human liver stem cellderived microvesicles inhibit hepatoma growth in SCIDmice by delivering antitumor microRNAs. Stem Cells 30:1985-98
154. Zitvogel L, Regnault A, Lozier A,Wolfers J, Flament C, et al. 1998. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat. Med. 4:594-600
155. Del Tatto M, Ng T, Aliotta JM, Colvin GA, Dooner MS, et al. 2011. Marrow cell genetic phenotype change induced by human lung cancer cells. Exp. Hematol. 39:1072-80
156. Andreola G, Rivoltini L, Castelli C, Huber V, Perego P, et al. 2002. Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J. Exp. Med. 195:1303-16
157. Azmi AS, Bao B, Sarkar FH. 2013. Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Cancer Metastasis Rev. 32:623-42
158. Aung T, Chapuy B, Vogel D, Wenzel D, Oppermann M, et al. 2011. Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3. PNAS 108:15336-41
159. Munoz JL, Bliss SA, Greco SJ, Ramkissoon SH, Ligon KL, Rameshwar P. 2013. Delivery of functional anti-miR-9 by mesenchymal stem cell-derived exosomes to glioblastoma multiforme cells conferred chemosensitivity. Mol. Ther. Nucleic Acids 2:e126
160. Aiastui A. 2015. Should cell culture platforms move towards EV therapy requirements Front. Immunol. 6:8
161. Smith A, Ng K, Mead E, Dopson S, Reeve B, et al. 2015. Extracellular vesicles commercial potential as byproducts of cell manufacturing for research and therapeutic use. Bioprocess Int. 13:20-28
162. Furman NET, Lupu-Haber Y, Bronshtein T, Kaneti L, Letko N, et al. 2013. Reconstructed stem cell nanoghosts: a natural tumor targeting platform. Nano Lett. 13:3248-55
163. Hu CMJ, Zhang L, Aryal S, Cheung C, Fang RH, Zhang LF. 2011. Erythrocytemembrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. PNAS 108:10980-85
164. Hu CM, Fang RH, Wang KC, Luk BT, Thamphiwatana S, et al. 2015. Nanoparticle biointerfacing by platelet membrane cloaking. Nature 526:118-21
165. Shelke GV, Lässer C, Gho YS, Lötvall J. 2014. Importance of exosome depletion protocols to eliminate functional and RNA-containing extracellular vesicles from fetal bovine serum. J. Extracell. Vesicles 3:24783
166. Stacey GN. 2014. The challenge of standardization in stem cell research and development. In Stem Cell Banking, ed. D Ilic, pp. 11-18. New York: Springer-Verlag
167. Jiang XR, Song A, Bergelson S, Arroll T, Parekh B, et al. 2011. Advances in the assessment and control of the effector functions of therapeutic antibodies. Nat. Rev. Drug Discov. 10:101-11
168. Tyndall A. 2014. Mesenchymal stem cell treatments in rheumatology: a glass half full Nat. Rev. Rheumatol. 10:117-24
169. Sahin U, Kariko K, Tureci O. 2014. mRNA-based therapeutics-developing a new class of drugs. Nat. Rev. Drug Discov. 13:759-80
170. Lener T, Gimona M, Aigner L, Borger V, Buzas E, et al. 2015. Applying extracellular vesicles based therapeutics in clinical trials-an ISEV position paper. J. Extracell. Vesicles 4:30087
171. GardnerCR, WalshCT, AlmarssonO. 2004. Drugs asmaterials: valuing physical form in drug discovery. Nat. Rev. Drug Discov. 3:926-34
172. van der Meel R, Krawczyk-DurkaM, van SolingeWW,Schiffelers RM. 2014. Toward routine detection of extracellular vesicles in clinical samples. Int. J. Lab. Hematol. 36:244-53
173. Saénz-CuestaM, Arbelaiz A, Oregi A, Irizar H, Osorio-Querejeta I, et al. 2015. Methods for extracellular vesicles isolation in a hospital setting. Front. Immunol. 6:50
174. Lin J, Li J, Huang B, Liu J, Chen X, et al. 2015. Exosomes: novel biomarkers for clinical diagnosis. Sci. World J. 2015:657086
175. De Toro J, Herschlik L, Waldner C, Mongini C. 2015. Emerging roles of exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applications. Front. Immunol. 6:203
176. Schwarzenbach H, Hoon DSB, Pantel K. 2011. Cell-free nucleic acids as biomarkers in cancer patients. Nat. Rev. Cancer 11:426-37
177. Crowley E,DiNicolantonio F, Loupakis F, Bardelli A. 2013. Liquid biopsy: monitoring cancer-genetics in the blood. Nat. Rev. Clin. Oncol. 10:472-84
178. de Gramont A, Watson S, Ellis LM, Rodon J, Tabernero J, et al. 2015. Pragmatic issues in biomarker evaluation for targeted therapies in cancer. Nat. Rev. Clin. Oncol. 12:197-212
179. Srivastava A, Filant J,Moxley KM, Sood A, McMeekin S, Ramesh R. 2015. Exosomes: a role for naturally occurring nanovesicles in cancer growth, diagnosis and treatment. Curr. Gene Ther. 15:182-92
180. Whiteside TL. 2015. The potential of tumor-derived exosomes for noninvasive cancer monitoring. Expert Rev. Mol. Diagn. 15:1293-310
181. Bellingham SA, Coleman BM, Hill AF. 2012. Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells. Nucleic Acids Res. 40:10937-49
182. Lashuel HA, Overk CR, Oueslati A, Masliah E. 2013. The many faces of-synuclein: from structure and toxicity to therapeutic target. Nat. Rev. Neurosci. 14:38-48
183. Fiandaca MS, Kapogiannis D, Mapstone M, Boxer A, Eitan E, et al. 2015. Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: a case-control study. Alzheimer's Dement. 11:600-7.e1
184. Lo YMD, Chiu RWK. 2012. Genomic analysis of fetal nucleic acids in maternal blood. Annu. Rev. Genom. Hum. Genet. 13:285-306
185. Gregg AR, Van den Veyver IB, Gross SJ, Madankumar R, Rink BD, Norton ME. 2014. Noninvasive prenatal screening by next-generation sequencing. Annu. Rev. Genom. Hum. Genet. 15:327-47
186. Beyer C, Pisetsky DS. 2010. The role of microparticles in the pathogenesis of rheumatic diseases. Nat. Rev. Rheumatol. 6:21-29
187. Buzas EI, Gÿorgy B, Nagy G, Falus A, Gay S. 2014. Emerging role of extracellular vesicles in inflammatory diseases. Nat. Rev. Rheumatol. 10:356-64
188. Hu L, Wickline SA, Hood JL. 2014. Magnetic resonance imaging of melanoma exosomes in lymph nodes. Magn. Reson. Med. 74:266-71
189. Lai CP, Mardini O, Ericsson M, Prabhakar S, Maguire CA, et al. 2014. Dynamic biodistribution of extracellular vesicles in vivo using a multimodal imaging reporter. ACS Nano 8:483-94
190. Cal ò A, Sanmart-Espinal M, Iavicoli P, Persuy MA, Pajot-Augy E, et al. 2012. Diffusion-controlled deposition of natural nanovesicles containing G-protein coupled receptors for biosensing platforms. Soft Matter 8:11632-43
191. Yuan A, Farber EL, Rapoport AL, Tejada D, Deniskin R, et al. 2009. Transfer of microRNAs by embryonic stem cell microvesicles. PLOS ONE 4:e4722
192. Ratajczak J, Miekus K, Kucia M, Zhang J, Reca R, et al. 2006. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 20:847-56
193. Wang Y, Zhang L, Li Y, Chen L,Wang X, et al. 2015. Exosomes/microvesicles from induced pluripotent stem cells deliver cardioprotective miRNAs and prevent cardiomyocyte apoptosis in the ischemic myocardium. Int. J. Cardiol. 192:61-69
194. Chou J, Mackman N, Merrill-Skoloff G, Pedersen B, Furie BC, Furie B. 2004. Hematopoietic cellderived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood 104:3190-97
195. Aoki J, Ohashi K, Mitsuhashi M, Murakami T, Oakes M, et al. 2014. Posttransplantation bone marrow assessment by quantifying hematopoietic cell-derived mRNAs in plasma exosomes/microvesicles. Clin. Chem. 60:675-82
196. Baglio SR, Rooijers K, Koppers-Lalic D, Verweij FJ, Pérez Lanzón M, et al. 2015. Human bonemarrowand adipose-mesenchymal stem cells secrete exosomes enriched in distinctivemiRNA and tRNA species. Stem. Cell Res. Ther. 6:127
197. Herrera MB, Fonsato V, Gatti S, Deregibus MC, Sordi A, et al. 2010. Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats. J. Cell Mol. Med. 14:1605-18
198. Cossetti C, Iraci N, Mercer TR, Leonardi T, Alpi E, et al. 2014. Extracellular vesicles from neural stem cells transfer IFN-via Ifngr1 to activate Stat1 signaling in target cells. Mol. Cell 56:193-204
199. Matusek T, Wendler F, Poles S, Pizette S, D'Angelo G, et al. 2014. The ESCRT machinery regulates the secretion and long-range activity of Hedgehog. Nature 516:99-103
200. Gradilla AC, Gonzalez E, Seijo I, Andres G, Bischoff M, et al. 2014. Exosomes as Hedgehog carriers in cytoneme-mediated transport and secretion. Nat. Commun. 5:5649
201. PirontiG, Strachan RT, Abraham D, Mon-Wei YS,ChenM, et al. 2015. Circulating exosomes induced by cardiac pressure overload contain functional angiotensin II type 1 receptors. Circulation 131:2120-30
202. Masyuk AI, Masyuk TV, Larusso NF. 2013. Exosomes in the pathogenesis, diagnostics and therapeutics of liver diseases. J. Hepatol. 59:621-25
203. Street JM, Birkhoff W, Menzies RI, Webb DJ, Bailey MA, Dear JW. 2011. Exosomal transmission of functional aquaporin 2 in kidney cortical collecting duct cells. J. Physiol. 589:6119-27
204. Lopez-Verrilli MA,Court FA. 2012. Transfer of vesicles from Schwann cells to axons: a novel mechanism of communication in the peripheral nervous system. Front. Physiol. 3:205
205. Sharma P, Schiapparelli L, ClineHT. 2013. Exosomes function in cell-cell communication during brain circuit development. Curr. Opin. Neurobiol. 23:997-1004
206. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, et al. 2008. Detection of microRNA expression in human peripheral blood microvesicles. PLOS ONE 3:e3694
207. Théry C, Duban L, Segura E, Véron P, Lantz O, Amigorena S. 2002. Indirect activation of näve CD4+ T cells by dendritic cell-derived exosomes. Nat. Immunol. 3:1156-62
208. Buschow SI, Nolte-'t Hoen ENM, van Niel G, PolsMS, ten Broeke T, et al. 2009. MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways. Traffic 10:1528-42
209. RaposoG,NijmanHW, StoorvogelW, Liejendekker R,Harding CV, et al. 1996. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183:1161-72
210. Admyre C, Bohle B, Johansson SM, Focke-Tejkl M, Valenta R, et al. 2007. B cell-derived exosomes can present allergen peptides and activate allergen-specific T cells to proliferate and produce TH2-like cytokines. J. Allerg. Clin. Immunol. 120:1418-24
211. Mittelbrunn M, Gutiérrez-Vazquez C, Villarroya-Beltri C, González S, Sánchez-Cabo F, et al. 2011. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat. Commun. 2:282
212. Ekstr öm K, Valadi H, Sjöstrand M, Malmhall C, Bossios A, et al. 2012. Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells. J. Extracell. Vesicles 1:18389
213. Xiao H, Lässer C, Shelke GV, Wang J, Ra°dinger M, et al. 2014. Mast cell exosomes promote lung adenocarcinoma cell proliferation-role of KIT-stem cell factor signaling. Cell Commun. Signal. 12:64